Modified release formulations of a bupropion salt
AssigneeBiovail Laboratories International S.R.L.
InventorsWerner Oberegger, Paul Maes, Mohammad Ashty Saleh
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
Claims8
A composition comprising bupropion hydrobromide and at least one other drug other than bupropion hydrobromide selected from the group consisting of anti-depressants, anti-anxiety agents, steroidal inflammatories, non-steroidal inflammatories, SSRIs, anti-migraine agents, anti-emetics, drugs for treating abuse, appetite modulators, anti-virals, vasodilators, anti-pain agents, and combinations thereof.
Dependencies are inferred from the claim text.